US Patent Issued to ALTO NEUROSCIENCE on May 12 for "Anti-neurodegenerative combinations and use for treatment of neurodegenerative diseases" (District Of Columbia Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,895, issued on May 12, was assigned to ALTO NEUROSCIENCE INC. (Mountain View, Calif.).

"Anti-neurodegenerative combinations and use for treatment of neurodegenerative diseases" was invented by Thomas N. Chase (Washington) and Kathleen E. Clarence-Smith (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a combination of a 5HT3-antagonist and/or a NK-1 antagonist with 6-propylamino-4,5,6,7-tetrahydro-1,3-benzothiazole-2-amine and with fluoxetine or a pharmaceutically acceptable salt or solvate thereof, zonisamide or a pharmaceutically acceptable salt or solvate thereof, or a statin or a pharmaceutically acceptable...